Novacyt Group acquires Southern Cross Diagnostics
Novacyt Group agreed to acquire Southern Cross Diagnostics. Reported deal value: Undisclosed. Status: Pending. Sector: Diagnostics. Target headquarters context: Banksmeadow, New South Wales, Australia.
This page summarizes publicly available information about the transaction as of 2026-02-23. Figures and status may change as filings and press coverage update.
Novacyt [ LON:NCYT ] Anglo-French diagnostics group Novacyt S.A. [ LON:NCYT ] has agreed a conditional acquisition of Australian distributor Southern Cross Diagnostics Pty Ltd in a transaction designed to accelerate its international growth trajectory and strengthen its pathway to profitability
Deal timeline
This transaction is classified in Diagnostics. Figures and status may change as sources update.